Effect of ciclesonide on bronchial asthma in athletes

Journal of Asthma

Volumn 46, Issue 10, 2009, Pages 1032-1036

  Koya, Toshiyuki ^a   Hasegawa, Takashi ^b   Tanaka, Junta ^a   Kawakami, Hidenori ^a   Hayashi, Masachika ^a   Kagamu, Hiroshi ^a   Narita, Ichiei ^a   Arakawa, Masaaki ^c   Suzuki, Eiichi ^b  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^c Niigata Institute for Health and Sports Medicine   (Japan)

Author keywords

Athlete; Bronchial asthma; Ciclesonide; Fraction of exhaled NO; Montelukast

Indexed keywords

CICLESONIDE; MONTELUKAST; NITRIC OXIDE;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; ATHLETE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE CONTROL; DRUG EFFECT; DRUG EFFICACY; EXERCISE INDUCED ASTHMA; FEMALE; FORCED EXPIRATORY VOLUME; GENERAL CONDITION IMPROVEMENT; HUMAN; JAPAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME;

ACETATES; ADOLESCENT; ASTHMA; ATHLETES; BREATH TESTS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MAXIMAL MIDEXPIRATORY FLOW RATE; NITRIC OXIDE; PREGNENEDIONES; QUINOLINES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VITAL CAPACITY; YOUNG ADULT;

EID: 72049096378     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770900903229693     Document Type: Article

References (21)

1. Weiler JM, Layton T, Hunt M. Asthma in United States Olympic athletes who participated in the 1996 Summer Games. J Allergy Clin Immunol 1998; 102:722-726.
2. Weiler JM, Ryan EJ, 3rd. Asthma in United States olympic athletes who participated in the 1998 olympic winter games. J Allergy Clin Immunol 2000; 106:267-271.
3. Rundell KW, Jenkinson DM. Exercise-induced bronchospasm in the elite athlete. Sports Med 2002; 32:583-600.
4. Manning P, Gibson PG, Lasserson TJ. Ciclesonide versus other inhaled steroids for chronic asthma in children and adults. Cochrane Database Syst Rev 2008: CD007031.
5. Pearlman DS, Van Adelsberg J, Philip G, Tilles SA, Busse W, Hendeles L, Loeys T, Dass SB, Reiss TF. Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast. Ann Allergy Asthma Immunol 2006; 97:98-104.
6. Philip G, Villaran C, Pearlman DS, Loeys T, Dass SB, Reiss TF. Protection against exercise-induced bronchoconstriction two hours after a single oral dose of montelukast. J Asthma 2007; 44:213-217.
7. Stelmach I, Grzelewski T, Majak P, Jerzynska J, StelmachW, Kuna P. Effect of different antiasthmatic treatments on exercise-induced bronchoconstriction in children with asthma. J Allergy Clin Immunol 2008; 121(2):383-389.
8. Alaranta A, Alaranta H, Palmu P, Alha P, Pietila K, HeliovaaraM, Helenius I. Asthma medication in Finnish olympic athletes: No signs of inhaled beta2-agonist overuse. Med Sci Sports Exerc 2004; 36(6):919-924.
9. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171:912-930.
10. Busse W, Corren J, Lanier BQ, McAlary M, Fowler-Taylor A, Cioppa GD, van As A, Gupta N. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 2001;108(2):184-190.
11. Tanaka J, Hasegawa T, Koya T, Hashiba M, Omori G, Gejyo F, Suzuki E, Arakawa M. Pulmonary function analysis of Japanese asthletes: Possibly even more asthmatics in the field. Allergo Int 2009; in press.
12. Fitch KD, Sue-Chu M, Anderson SD, Boulet LP, Hancox RJ, McKenzie DC, Backer V, Rundell KW, Alonso JM, Kippelen P, Cummiskey JM, Garnier A, Ljungqvist A. Asthma and the elite athlete: Summary of the International Olympic Committee's consensus conference, Lausanne, Switzerland, January 22-24, 2008. J Allergy Clin Immunol 2008; 122(2):254-260, e251-257.
13. Chimenti L, Morici G, Paterno A, Bonanno A, Siena L, Licciardi A, Veca M, Guccione W, Macaluso F, Bonsignore MR. Endurance training damages small airway epithelium in mice. Am J Respir Crit Care Med 2007; 175(5):442-449.
14. Locke S, Marks G. Are the prevalence and treatment of asthma similar in elite athletes and the aged-matched non-athlete population? Scand J Med Sci Sports 2007; 17:623-627.
15. Fitch KD. Beta2-Agonists at the Olympic Games. Clin Rev Allergy Immunol 2006; 31:259-268.
16. Sue-ChuM, Larsson L,Moen T, Rennard SI, Bjermer L. Bronchoscopy and bronchoalveolar lavage findings in cross-country skiers with and without "ski asthma". Eur Respir J 1999; 13:626-632.
17. Sue-ChuM, Karjalainen EM, Laitinen A, Larsson L, Laitinen LA, Bjermer L. Placebo-controlled study of inhaled budesonide on indices of airway inflammation in bronchoalveolar lavage fluid and bronchial biopsies in crosscountry skiers. Respiration 2000; 67(4):417-425.
18. Hasegawa T, Suzuki E, Toyabe S, Akazawa K, Kawano K, Haraguchi M, Toyama J,Watanabe Y,Watanabe N, Arakawa M, Satoh H, Gejyo F, Group NITS. Drug compliance in patients with bronchial asthma: Relation among compliance with different types of antiasthmatic drug and association with daily administration frequency. Allergo Int 2005; 54.
19. Subbarao P, Duong M, Adelroth E, Otis J, Obminski G, ImmanM, Pedersen S, O'Byrne PM. Effect of ciclesonide dose and duration of therapy on exercise-induced bronchoconstriction in patients with asthma. J Allergy Clin Immunol 2006; 117(5):1008-1013.
20. Villaran C, O'Neill SJ, Helbling A, van Noord JA, Lee TH, Chuchalin AG, Langley SJ, Gunawardena KA, Suskovic S, Laaurenzi M, Jasan J, Menten J, Leff JA. Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukast/Salmeterol Exercise Study Group. J Allergy Clin Immunol 1999; 104(3 Pt 1):547-553.
21. Steinshamn S, Sandsund M, Sue-ChuM, Bjermer L. Effects of montelukast and salmeterol on physical performance and exercise economy in adult asthmatics with exercise-induced bronchoconstriction. Chest 2004; 126:1154-1160.